ABSTRACT Dyslipidemia in chronic kidney disease (CKD) contributes to the increasing cardiovascular risk during progression of disease. Statins reduces ischemic events CKD patients not treated with dialysis and treatment is generally recommended above 50 years old. In on maintenance treatment, it initiate statins based evidence from randomized clinical trials. an article by Marx et al. this issu...